What is Phytochem Remedies IPO GMP Today?
The Latest GMP of Phytochem Remedies IPO is ₹0.
Phytochem Remedies IPO GMP
| DATE | GMP (GREY MARKET PREMIUM) | EXPECTED LISTING GAINS |
|---|---|---|
| 22-Dec-2025 | – | – |
| 21-Dec-2025 | – | – |
| 20-Dec-2025 | – | – |
| 19-Dec-2025 | – | – |
| 18-Dec-2025 | – | – |
IPO Grey Market Premium (GMP) – Phytochem Remedies IPO GMP
The grey market premium (GMP) represents the informal trading price in grey market of an IPO before it officially lists on the stock exchange. The GMP can provide an early snapshot of investor sentiment and the expected demand for shares once they are listed. A higher GMP generally suggests positive market expectations, while a lower or negative GMP may indicate cautious sentiment.
It is important to remember that GMP values are purely indicative and can change rapidly due to short-term market factors, speculative trading, or investor perception. They do not guarantee how the IPO will perform on the listing day.
Investors should not base their investment decision solely on GMP. Instead, a careful analysis of the company’s business model, financial health, industry position, and growth potential should guide the decision to participate in the IPO. Using GMP as one of many reference points can help, but relying on it alone carries significant risk.
Company Brief – Phytochem Remedies (India) Limited – Phytochem Remedies IPO GMP
Phytochem Remedies (India) Limited is a manufacturing company specializing in corrugated packaging solutions, including corrugated boxes (3-ply, 5-ply, 7-ply), printed boxes, rolls, pads, and sheets. The company’s products serve multiple industries such as FMCG, food & beverages, pharmaceuticals, pesticides, automotive and industrial segments.
Incorporated in 2002, with manufacturing operations beginning in 2014, Phytochem Remedies operates two manufacturing facilities in Bari Brahmana, Jammu, strategically located to serve clients across India. The company, as of 30 September 2025, employs 51 people focused on production, quality control, and distribution.
The company’s revenue and profitability have shown a consistent year-on-year increase, with total revenue growing from ₹32.90 crore in FY24 to ₹36.81 crore in FY25, and net profit nearly doubling from ₹2.31 crore in FY24 to ₹4.48 crore in FY25. For the six months ended 30 September 2025, the company reported total revenue of ₹25.01 crore and net profit after tax of ₹3.75 crore.
Phytochem Remedies aims to leverage its established manufacturing base and diversified industry exposure to expand capacity, improve operational efficiency, and meet rising demand for customized packaging solutions.
IPO Dates
| Event | Date |
| Issue Opening Date | 18 December 2025 |
| Issue Closing Date | 22 December 2025 |
| Basis of Allotment* | 23 December 2025 |
| Refund Initiation | 24 December 2025 |
| Shares Credited to Demat | 24 December 2025 |
| IPO Listing Date* | 26 December 2025 |
IPO Details
| Particulars | Details |
| Issue Price | ₹98 per equity share |
| Face Value | ₹10 per share |
| Market Lot | 1,200 shares |
| Minimum Investment (Retail) | ₹2,35,200 for 2 lots (2,400 shares) |
| HNI Minimum Investment | ₹3,52,800 for 3 lots (3,600 shares) |
| Issue Size | ₹38.22 crore |
| Total Shares Offered | 39,00,000 shares |
| Issue Type | Fixed Price Fresh Issue |
| Listing Platform | BSE SME Exchange |
| Pre-IPO Equity | 78,75,000 shares |
| Post-IPO Equity | 1,17,75,000 shares (approx) |
Objects of the Issue
The company has stated that IPO proceeds will be used for the following purposes:
1. Capital Expenditure & Machinery Purchase
A significant portion of funds will go toward upgrading and acquiring new machinery to enhance production capacity and efficiency.
2. Civil Construction & Infrastructure
Investment in expanding plant infrastructure to support future growth and scale operations.
3. General Corporate Purposes
Includes working capital support, administrative costs, and other business needs to strengthen financial flexibility.
4. Debt Repayment
Part of the proceeds may be used to reduce existing borrowings, improving the company’s balance sheet structure. (IPO Premium)
Financials (₹ in Crore)
| Period Ended | Total Revenue | Profit After Tax |
| 31 March 2023 | ₹20.83 Cr | ₹0.82 Cr |
| 31 March 2024 | ₹32.90 Cr | ₹2.31 Cr |
| 31 March 2025 | ₹36.81 Cr | ₹4.48 Cr |
| 30 Sep 2025 (H1 FY26) | ₹25.01 Cr | ₹3.75 Cr |
Phytochem Remedies IPO GMP
Phytochem Remedies IPO is a fixed-price, fresh issue of ₹38.22 crore, opening on 18 December 2025 and closing on 22 December 2025. With a fixed price of ₹98 per share and a minimum retail investment of ₹2,35,200, the IPO offers a structured opportunity to participate in the company’s growth. Though current GMP is neutral, the stock’s performance at listing on 26 December 2025 will hinge on market conditions and demand. Detailed financials show consistent revenue and profit growth, signaling operational progress and industry relevance.